Biggest News Aggregation in the World
📰 Collaboration Partner News

Page 2 - Collaboration Partner News Today

Fast, Ad-Free News Updates

Stay updated with breaking news from Collaboration Partner. Real-time updates on events, politics, business and more.

Adhoc: Relief Therapeutics Holding SA: Relief Therapeutics Announces that its Collaboration Partner has Resubmitted the ACER-001 (sodium phenylbutyrate) New Drug Application (NDA) to the FDA for the treatment of urea cycle disorders (UCDs)

Relief Therapeutics Holding SA / Key word(s): Regulatory Approval Relief Therapeutics Announces that its Collaboration Partner has Resubmitted the ACER-001 (sodium phenylbutyrate) New Drug Application
Switzerland General Michael Miller Jack Weinstein Advita Lifescience Gmb Relief Therapeutics Holding Sa Key Pharma Research

Adhoc: Relief Therapeutics Holding SA: Relief Reports that its Collaboration Partner, Acer Therapeutics, Issued a Statement Regarding the PDUFA Target Action Date for ACER-001

Relief Therapeutics Holding SA / Key word(s): Regulatory Approval Relief Reports that its Collaboration Partner, Acer Therapeutics, Issued a Statement Regarding the PDUFA Target Action Date for ACER-001
Switzerland General Michael Miller Jack Weinstein Advita Lifescience Gmb Relief Therapeutics Holding Sa Key Pharma Research

Relief Reports that its Collaboration Partner, Acer Therapeutics, Issued a Statement Regarding the P

Relief Therapeutics Holding SA / Key word(s): Regulatory Approval08-Jun-2022 / 07:00 CET/CESTRelease of an ad hoc announcement pursuant to Art. 53 LRThe issuer is solely responsible for the content of this announcement.Relief Reports that its Collaboration Partner, Acer Therapeutics, Issued a Statement Regarding the...
Michael Miller Jack Weinstein Advita Lifescience Gmb Relief Therapeutics Holding Sa Key Pharma Research Drug Administration

Relief Therapeutics Reports that its Collaboration Partner, NRx Pharmaceuticals, has Submitted an Ap

EQS Group-News: RELIEF THERAPEUTICS Holdings AG / Key word(s): Miscellaneous02.06.2021 / 07:00 Relief Therapeutics Reports that its Collaboration Partner, NRx Pharmaceuticals, has Submitted an Application for Emergency Use Authorization for Aviptadil to the U.S. Food & Drug Administration Geneva, Switzerland, Ju...
United States Anne Hennecke Raghuram Ram Selvaraju Jack Weinstein Mc Services Human Services

Stay Updated with Latest News

Get breaking news updates delivered to your inbox

Browse All News →

Explore More Categories

World News India News Business Technology Sports Entertainment Health Science